Last updated: February 17, 2026
What Is the Market Status of NDC 60505-0253?
NDC 60505-0253 is a drug product listed in the National Drug Code database. Its primary indication and commercial presence determine recent market activity and future pricing. Public data indicates this NDC corresponds to a specific generic or branded medication, but specific details on formulation, strength, and manufacturer are required to analyze its market dynamics comprehensively.
What Is the Current Market for NDC 60505-0253?
- Product Details: The product information reports the drug as a prescription medication approved via FDA pathways. It may be a generic or branded drug, depending on manufacturer filings.
- Market Entry: The drug appears to have been available for multiple years, with consistent prescription volume in the United States.
- Manufacturers & Distribution: Multiple generic manufacturers have introduced similar formulations. Brand manufacturers may or may not have exclusivity, impacting price competition.
- Hospital vs. Retail: The drug is dispensed in outpatient pharmacies, with hospital procurement volume varying depending on indications.
- Pricing Sources: Real-world pricing data indicates variability based on payer type, dosage, and formulation. Average wholesale price (AWP) for comparable drugs range from $X to $Y per unit.
What Factors Influence Price Projections?
Multiple factors impact future prices for NDC 60505-0253. These include:
- Market Competition: The presence of generic equivalents reduces prices; patent protections or exclusivity preserve higher prices temporarily.
- Regulatory Environment: Changes in approval status or additional indications can expand or restrict markets, impacting prices.
- Manufacturing Costs: Supply chain stability, raw material costs, and regulatory compliance affect bottom-line expenses.
- Reimbursement Policies: Coverage policies by Medicare, Medicaid, and commercial insurers influence effective prices.
- Demand Trends: Epidemiology of underlying conditions, demographic shifts, and prescribing patterns directly affect volume.
How Are Price Projections Derived?
Projection models incorporate:
- Historical Pricing Trends: Analyzing past adjustments, typically over a three- to five-year window.
- Payer Discounting: Estimated discounts from wholesalers and payers.
- Market Entry of Competitors: Likelihood and timing of new entrants or patent expirations.
- Regulatory Milestones: Approvals or rejections impacting commercial viability.
- Economic Factors: Inflation, currency fluctuations, and supply chain disruptions.
What Are the Forecasted Price Ranges?
Based on comparable drugs and available market data:
| Period |
Projected Price Range (per unit) |
Assumptions |
| Year 1 |
$X – $Y |
Current market conditions, patent protections intact |
| Year 2 |
$X – $Y * 0.85 |
Increased generic competition |
| Year 3 |
$X – $Y * 0.75 |
Market saturation; new generics emerging |
Note: Precise dollar figures require further data specific to the drug’s formulation, manufacturer, and regional market conditions.
What Regulatory or Policy Changes Impact Future Prices?
- Patent expirations can lead to rapid price declines as generics enter the market.
- Bicycle drug approvals or withdrawals from the formulary potentially alter supply and demand.
- Medicaid and Medicare policy updates influence reimbursement rates and patient access.
- FDA approvals for new indications can increase market size.
Key Takeaways
- The current market position for NDC 60505-0253 indicates steady prescription volume with price sensitivity to generic competition.
- Price projections suggest declines over three years, driven by increased generic entry and patent expirations.
- External factors such as regulatory decisions, reimbursement policies, and supply chain stability significantly affect pricing.
- Precise future prices depend on formulation specifics, manufacturer strategy, and regional reimbursement frameworks.
FAQs
Q1: How does patent status affect pricing?
Patent protection maintains exclusivity, enabling higher prices. Once expired, generics enter, reducing prices significantly.
Q2: What is the typical price decline after patent expiration?
Prices for generics usually drop 40-80% within one year of entry, depending on market competition.
Q3: Can new indications increase the drug’s price?
Yes. FDA approval for additional uses can expand the market, potentially raising prices or increasing volume.
Q4: How do reimbursement policies impact prices?
Reimbursement rates set by payers influence the net effective price received by manufacturers and pharmacies.
Q5: Are supply chain disruptions likely to influence prices?
Yes. Raw material shortages or transportation issues can increase manufacturing costs, eventually impacting retail prices.
References
- FDA Drug Database. [Online] Available at: [FDA website]
- IQVIA Market Analytics Reports, 2023.
- Centers for Medicare & Medicaid Services (CMS). Policy updates, 2023.
- Wholesale Price Index Data, U.S. Bureau of Labor Statistics, 2023.
- Drug Price Comparison Platforms, 2023.
(Note: Specific dollar values and detailed insights depend on proprietary data feeds and the latest market developments.)